Risks for diabetes, CVD up in acute, postacute COVID-19 phases
Jul 20, 2022
However, from 13 to 52 weeks after COVID-19, no increase was seen for diabetes mellitus or cardiovascular disease.
Heart, diabetes, cancer drugs on list for Medicare price negotiations, White House says
Aug 29, 2023
Enrollees in the Medicare prescription drug program paid a total of $3.4 billion in out-of-pocket costs in 2022 for the 10 initial drugs chosen for price negotiations.
Hypertension linked to hospitalization for omicron in vaccinated persons
Aug 09, 2022
The findings were seen among individuals who received at least three mRNA vaccine doses and in whom COVID-19 subsequently was diagnosed during omicron surge.
‘Nanopaint’ breakthrough could give seniors a picture-perfect recovery from heart surgery, dialysis
By
Aaron Dorman
Mar 12, 2024
In the future, surgeons could use “nanopaint” particles to coat veins to prevent clogging after vein transplant procedures, research shows.
Life expectancy decreasing, CDC says
By
Lois A. Bowers
Aug 15, 2018
Life expectancy in the United States decreased in both 2015 and 2016, marking the only decreases in the past 20 years and the first consecutive two-year decline since 1964, according to a new report from...
AI-informed health app aids diabetes outcomes
May 15, 2024
The app gives tailored nutrition and health recommendations, which are linked to decreases in HbA1c and heart disease risk.
Technology-use changes essential to reducing loneliness ‘epidemic,’ surgeon general warns
By
John O'Connor
May 05, 2023
Reforming digital environments can help reduce a loneliness epidemic that disproportionately affects the elderly, according to US Surgeon General Vivek Murthy, MD.
21.2 percent of U.S. adults had diagnosed arthritis from 2019 to 2021
Oct 12, 2023
Age-standardized prevalence rates were higher among women than men, veterans than nonveterans and non-Hispanic whites.
Discordance seen in self-reported, actual comorbidities in Native American adults
Jul 18, 2023
One-third reported having no comorbidities despite cardiometabolic markers classifying half to 80%.
BP genetic risk score linked to risk for CV events in type 2 diabetes
Apr 04, 2022
Each standard deviation increase in BP polygenic risk score was linked to a 12% increased hazard of adverse cardiovascular events.